NCT02257541: BGJ398 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST) |
|
|
| Completed | 1/2 | 16 | US | BGJ398, Imatinib Mesylate | Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, M.D. Anderson Cancer Center, University of Pittsburgh | Advanced Gastrointestinal Stromal Tumor (GIST) | 03/19 | 03/19 | | |
